Triveni Bio
Develops novel antibody treatments for immunological and inflammatory disorders
$65MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops novel antibody treatments for immunological and inflammatory disorders
Develops inhaled therapies for severe respiratory diseases
Pitching Atlas Venture? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room